Tier 3 visitation restrictions are currently in place, please review before coming to the facility.
Individuals 5 years of age and older are eligible for COVID-19 vaccinations at Newman Regional Health by appointment. 3rd and boost doses of the Moderna and Janssen COVID-19 vaccines for all eligible individuals in addition to continuing administration of the Pfizer-BioNTech vaccine.
Schedule an appointment:
- Call the COVID-19 vaccine scheduling help center at (620) 343-6801 Monday thru Friday from 8:00am to 4:30pm.
- During a visit with a primary care provider.
- By filling out a COVID-19 Vaccination/Test Appointment request
Newman Regional Health provides COVID-19 Testing Monday thru Friday. Nasal swab testing only, by appointment.
To schedule: (620) 343-6801
COVID-19 AND PREGNANCY
If you are pregnant, plan to become pregnant, or are breastfeeding, review frequently asked questions about the COVID-19 vaccine.
|COVID-19 Vaccines Authorized in the United States|
|Vaccine type||mRNA||mRNA||viral vector|
|Authorized age groups||5 – 11 years||≥12 years||≥ 18 years||≥ 18 years|
|Number of doses in initial series||2||2||2||1|
|Interval between doses in initial series||21 days||21 days||28 days||n/a|
|Dose volume||0.2 mL pediatric formula||0.3 mL||0.5 mL||0.5 mL|
|FDA status||Emergency Use Authorization||Approved||Emergency Use Authorization||Emergency Use Authorization|
|Individuals may receive influenza and any other vaccines at the same time as a COVID-19 vaccine.|
|Interval between initial series and booster||5 months||6 months||2 months|
|Dose volume||0.3 mL||0.25 mL||0.5|
|Individuals qualifying for booster||≥ 12 years old||≥ 18 years old||≥ 18 years old|
|FDA status||Emergency Use Authorization||Emergency Use Authorization||Emergency Use Authorization|
|Heterologous (or “mix and match”) booster doses are allowed following the eligibility requirements of the individual’s primary COVID-19 vaccine.|
|Authorized 3rd dose||yes||yes||n/a|
|Interval between initial series and 3rd dose||28 days||28 days||n/a|
|Dose volume||0.3 mL||0.5 mL||n/a|
|Individuals qualifying for 3rd dose||≥5 years||≥ 18 years||n/a|
|Moderate or severely immunocompromised individuals:||Moderate or severely immunosuppressed individuals:||n/a|
|Receiving active cancer treatment for tumors or cancers of the blood||Receiving active cancer treatment for tumors or cancers of the blood|
|Received an organ transplant and are taking medicine to suppress the immune system||Received an organ transplant and are taking medicine to suppress the immune system|
|Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system||Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system|
|Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome or Wiskott-Aldrich syndrome)||Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome or Wiskott-Aldrich syndrome)|
|Have advanced HIV infection (high viral load or low CD4 count)or untreated HIV infection||Have advanced HIV infection (high viral load or low CD4 count)or untreated HIV infection|
|Active treatment with high-dose corticosteroids or other drugs that may suppress immune response||Active treatment with high-dose corticosteroids or other drugs that may suppress immune response|
|FDA status||Emergency Use Authorization||Emergency Use Authorization||n/a|
|Additional 3rd doses should be the same vaccine type as the individual’s primary COVID-19 vaccine if available.|